Plant-derived pharmaceuticals : principles and applications for developing countries
Materia medica, Vegetable -- Developing countries. Medicinal plants -- Biotechnology -- Developing countries. Pharmaceutical biotechnology -- Developing countries. Vaccines -- Biotechnology -- Developing countries. Monoclonal antibodies -- Biotechnolo sähkökirjat
CABI
2014
EISBN 9781780643441
Contents; Contributors; 1 Introduction, and the Promise of a Plant-derived Vaccine for Hepatitis B Virus; 1.1 Introduction; 1.2 Hepatitis B Virus; References; 2 Protein Body-inducing Fusions for Recombinant Protein Production in Plants; 2.1 Introduction; 2.2 Nicotiana tabacum as a Plant-based Production Platform; 2.3 Plant Seeds: Organs Naturally Suited for Protein Storage; 2.4 Adapting Seed Mechanisms to Improve Leaf-based Production Systems; 2.5 Fusion Partners as Enhancers of Recombinant Protein Accumulation and PB Inducers; 2.5.1 Elastin-like polypeptides as fusion partners
2.5.2 Hydrophobin I as a fusion partner2.6 Elastin-like Polypeptide and HFBI I Fusions in Transgenic Tobacco; 2.7 Conclusions; Acknowledgement; References; 3 Expression of Recombinant Proteins in Plant Cell Culture; 3.1 Introduction; 3.2 Different Plant Cell Culture Platforms to Produce Recombinant Molecules; 3.2.1 Plant cell suspension culture; 3.2.2 Culture of h
Describing recent developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes both vaccines and monoclonal antibodies. It has a particular emphasis on targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications. This book also includes a variety of vaccine case studies, protecting against pervasive infectious diseases such as rabies, influenza and HIV.
2.5.2 Hydrophobin I as a fusion partner2.6 Elastin-like Polypeptide and HFBI I Fusions in Transgenic Tobacco; 2.7 Conclusions; Acknowledgement; References; 3 Expression of Recombinant Proteins in Plant Cell Culture; 3.1 Introduction; 3.2 Different Plant Cell Culture Platforms to Produce Recombinant Molecules; 3.2.1 Plant cell suspension culture; 3.2.2 Culture of h
Describing recent developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes both vaccines and monoclonal antibodies. It has a particular emphasis on targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications. This book also includes a variety of vaccine case studies, protecting against pervasive infectious diseases such as rabies, influenza and HIV.
